FSTX - F-star Therapeutics GAAP EPS of -$0.88 August, 11 2022 09:03 AM F-star Therapeutics Inc Com F-star Therapeutics press release ( NASDAQ: FSTX ): Q2 GAAP EPS of -$0.88. Cash and cash equivalents were $53.0 million as of June 30, 2022, compared to $78.5 million at December 31, 2021. For further details see: F-star Therapeutics GAAP EPS of -$0.88